Cargando…
Immunotherapy of Nivolumab with Dendritic Cell Vaccination Is Effective against Intractable Recurrent Primary Central Nervous System Lymphoma: A Case Report
We report effective treatment with nivolumab of a patient with recurrent primary central nervous system lymphoma (PCNSL) after multiple therapies. A 41-year-old woman with a right parietal PCNSL underwent treatment with high-dose methotrexate and radiotherapy. After recurrence in the left frontal lo...
Autores principales: | FURUSE, Motomasa, NONOGUCHI, Naosuke, OMURA, Naoki, SHIRAHATA, Mitsuaki, IWASAKI, Koichi, INUI, Toshio, KUROIWA, Toshihiko, KUWABARA, Hiroko, MIYATAKE, Shin-Ichi |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Japan Neurosurgical Society
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5409273/ https://www.ncbi.nlm.nih.gov/pubmed/28331101 http://dx.doi.org/10.2176/nmc.cr.2016-0330 |
Ejemplares similares
-
The roles of platelet-derived growth factors and their receptors in brain radiation necrosis
por: Miyata, Tomo, et al.
Publicado: (2014) -
Intratumoral and peritumoral post-irradiation changes, but not viable tumor tissue, may respond to bevacizumab in previously irradiated meningiomas
por: Furuse, Motomasa, et al.
Publicado: (2015) -
Inflammation as well as angiogenesis may participate in the pathophysiology of brain radiation necrosis
por: Yoritsune, Erina, et al.
Publicado: (2014) -
Radiological diagnosis of brain radiation necrosis after cranial irradiation for brain tumor: a systematic review
por: Furuse, Motomasa, et al.
Publicado: (2019) -
NI-04 WHICH RADIOLOGICAL IMAGING IS BEST TO DISCRIMINATE RADIATION NECROSIS FROM TUMOR PROGRESSION? - SUBANALYSIS OF SYSTEMATIC REVIEW FOR RADIOLOGICAL DIAGNOSIS OF RADIATION NECROSIS
por: Furuse, Motomasa, et al.
Publicado: (2019)